PharmaMénta Aps: Financial statements 2017
CVR: 25615697
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PharmaMénta Aps (CVR 25615697) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,119,779 and a net result of DKK -5,137,618 compared with DKK 1,149,828 the year before. That is a decrease of 16.6% compared with the year before. Equity in the 2017 report amounted to DKK 475,631. The solvency ratio was 99%.
- Gross Profit
- DKK 1,119,779
- Profit/Loss
- DKK -5,137,618
- Equity
- DKK 475,631
- Total Assets
- DKK 480,631
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.1 mio. | -5.1 mio. | 476 t. | - |
| 2016 | - | 1.3 mio. | 1.1 mio. | 5.6 mio. | - |
| 2015 | - | 126 t. | 204 t. | 4.5 mio. | - |
| 2014 | - | -2 t. | 125 t. | 4.3 mio. | - |
| 2013 | - | -7 t. | 136 t. | 4.1 mio. | - |
Official annual report
Keep an eye on PharmaMénta Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PharmaMénta Aps has published its annual report for 2016. Gross profit came to DKK 1,342,922, and the net result was DKK 1,149,828.
About PharmaMénta Aps
PharmaMénta Aps is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jimmi Javed Christensen Malik. The board consists of Lasse Hvingelby Kikkenborg (chair), Jimmi Javed Christensen Malik and Torben Hvingelby Pedersen. The company is owned by Torben Hvingelby Pedersen, LHK Holding Esbjerg ApS and JMINT Holding ApS. The company has 3 employees (2008). In 2025, the company reported a gross profit of DKK 5,249,012 and a net result of DKK 2,364,968 compared with DKK 2,121,363 the year before. Equity in the 2025 report amounted to DKK 5,130,022.